
Maine Angels
Description
Maine Angels is a prominent angel investment group based in Portland, Maine, dedicated to fostering the growth of early-stage companies primarily within Maine and the broader northern New England region. Comprised of accredited private equity investors, the group provides crucial seed and early-stage capital to innovative startups that have moved beyond the initial "friends and family" funding but are not yet mature enough for traditional venture capital firms. Their mission centers on identifying and nurturing high-potential businesses with the capacity for significant growth and economic impact in the region.
The group's investment strategy is focused on companies demonstrating strong management teams, substantial market opportunities, and a clear, viable path to exit. While sector-agnostic to some extent, Maine Angels has shown a propensity to invest across diverse industries including technology, life sciences, advanced manufacturing, and consumer products. They typically seek companies that are poised for commercialization and have a defensible competitive advantage, aiming to support ventures that can scale and generate significant returns.
Maine Angels typically deploys initial investments ranging from $100,000 to $500,000 in a first round. These investments are frequently part of larger syndicates, where Maine Angels collaborates with other angel groups, venture capital firms, and strategic partners to provide more substantial funding rounds. Since its inception in 2003, the group has been a significant catalyst for regional economic development, having invested in over 70 companies and facilitating more than $30 million in capital to these ventures, underscoring their commitment to building a robust entrepreneurial ecosystem in Maine.
Investor Profile
Maine Angels has backed more than 137 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 1% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Angel rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Typical check size: $100K – $500K.
Stage Focus
- Seed (34%)
- Series Unknown (29%)
- Angel (13%)
- Series A (10%)
- Series B (6%)
- Debt Financing (4%)
- Convertible Note (2%)
- Pre Seed (1%)
- Non Equity Assistance (1%)
Country Focus
- United States (99%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Manufacturing
- Therapeutics
- Information Technology
- Medical Device
- Food And Beverage
- Education
- Medical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.